{
    "2018-01-01": [
        [
            {
                "time": "",
                "original_text": "医药生物行业点评：首批通过一致性评价品种公布关注业绩弹性",
                "features": {
                    "keywords": [
                        "医药生物",
                        "一致性评价",
                        "首批通过",
                        "业绩弹性"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}